Trial Profile
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Sep 2015
Price :
$35
*
At a glance
- Drugs TRV 734 (Primary) ; Oxycodone
- Indications Acute pain; Pain
- Focus Adverse reactions
- Sponsors Trevena
- 08 Sep 2015 Data from this trial will be presented at the PAINWeek, the National Conference on Pain for Frontline Practitioners 2015, according to a Trevena medial release.
- 09 Feb 2015 Results published in a Trevena media release.
- 04 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov